Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nina Schoenwaelder"'
Autor:
Charlotte Linke, Thomas Freitag, Christin Riess, Jana Vanessa Scheffler, Katharina del Moral, Nina Schoenwaelder, Tomas Fiedler, Adina Fiebig, Philipp Kaps, Daniel Dubinski, Björn Schneider, Wendy Bergmann, Carl Friedrich Classen, Claudia Maletzki
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-18 (2023)
Abstract Background Arginine auxotrophy constitutes a shortcoming for ~ 30% of glioblastoma multiforme (GBM). Indeed, arginine-depleting therapy using arginine deiminase from Streptococcus pyogenes (SpyADI) has proven activity against GBM in preclini
Externí odkaz:
https://doaj.org/article/b688d5f6f21b43c69fa8ffaf7d1c4143
Autor:
Daniel Strüder, Thoralf Kleitke, Alina-Sophie Christiansen, Nina Schoenwaelder, Friederike Poosch, Robert Mlynski, Claudia Maletzki
Publikováno v:
Abstract- und Posterband - 93. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn Interface - Fokus Mensch im Zeitalter der technisierten Medizin.
Autor:
Daniel Strüder, Thoralf Kleitke, Alina-Sophie Christiansen, Nina Schoenwaelder, Friederike Poosch, Robert Mlynski, Claudia Maletzki
Publikováno v:
Abstract- und Posterband - 93. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn Interface - Fokus Mensch im Zeitalter der technisierten Medizin.
Autor:
Nina Schoenwaelder, Mareike Krause, Thomas Freitag, Björn Schneider, Sarah Zonnur, Annette Zimpfer, Anne Sophie Becker, Inken Salewski, Daniel Fabian Strüder, Heiko Lemcke, Christina Grosse-Thie, Christian Junghanss, Claudia Maletzki
Publikováno v:
Cancers; Volume 14; Issue 10; Pages: 2484
This study aimed to refine combined targeted approaches on well-characterized, low-passage tumor models. Upon in vivo xenografting in immunodeficient mice, three cell lines from locally advanced or metastatic HNSCC were established. Following quality
Autor:
Mareike Krause, Heiko Lemcke, Michael W. Müller, Christina Grosse-Thie, Christin Riess, Björn Schneider, Inken Salewski, Claudia Maletzki, Nadja Engel, Nina Schoenwaelder, Christian Junghanss, Anna Skorska
Publikováno v:
Cancers
Volume 13
Issue 10
Cancers, Vol 13, Iss 2396, p 2396 (2021)
Volume 13
Issue 10
Cancers, Vol 13, Iss 2396, p 2396 (2021)
Simple Summary This study examined the therapeutic potential of a combined therapy approach, based on clinical approved drugs (5-FU, Cisplatin, cetuximab) and cyclin-dependent kinase inhibitors (CDKi, dinaciclib, palbociclib, THZ1). We identified ind
Publikováno v:
Cancers
Cancers, Vol 13, Iss 2497, p 2497 (2021)
Cancers, Vol 13, Iss 2497, p 2497 (2021)
Simple Summary Cyclin-dependent kinases are involved in the regulation of cancer-initiating processes like cell cycle progression, transcription, and DNA repair. In hematological neoplasms, these enzymes are often overexpressed, resulting in increase